Furthermore, there may be differential effects of CD4+ T cell subsets on stroke outcome, such as exacerbation by Th1 cells and amelioration by Th2 cells of brain infarct development and functional deficit (Xiong et al., 2011; Gu et al., 2012). The gene discussed is CD4; the disease is stroke disorder.